Expanding on these questions by performing the mentioned analyses in a larger cohort of HCC patients could help further determine whether SNHG1 expression patterns correlate well with different stages in disease, so that the quantification of serum levels of SNHG1 can be advocated as a reliable prognostic or monitoring method to assess HCC patients. The gene discussed is SNHG1; the disease is hepatocellular carcinoma.